Myositis ℞: Lung

A multicenter study assessed patients with the antisynthetase syndrome (AS) and interstitial…

Rituximab in the Treatment of Interstitial Lung Disease Associated with Antisynthetase Syndrome: A Multicenter Retrospective Case Review

Patients with Antisynthetase Syndrome who are also anti-Ro52 positive are at heightened risk of developing severe interstitial lung disease refractory to most immunosuppressants except Rituximab.

Objective Patients with myositis-associated interstitial lung disease (MA-ILD) are often refractory to conventional treatment, and predicting…

No Comments Yet.

Leave a comment